United States · FDA National Drug Code directory
Ambrisentan
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 69097-387_7921a3aa-6e99-4f28-a5d3-a3047b1ec3cc
- Product NDC
- 69097-387
- Form
- TABLET, FILM COATED
- Composition / generic term
- Ambrisentan
- Labeler
- Cipla USA Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20190426
- Source listing expiry
- 20261231
Source-listed ingredients
- AMBRISENTAN — 10 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (69097-387-02) · 69097-387-02
- 1 BLISTER PACK in 1 CARTON (69097-387-19) / 10 TABLET, FILM COATED in 1 BLISTER PACK · 69097-387-19
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →